Stockreport

Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 [Yahoo! Finance]

Standard BioTools Inc.  (LAB) 
PDF Revenues and losses per share were both better than expected, with revenues of US$45m leading estimates by 9.7%. Statutory losses were smaller than the analystsexpected, [Read more]